Cancer Genetics Inc., a budding leader in DNA-based cancer diagnostics, proclaimed receiving a third US patent covering FHACT (US patent number 9,157,129), its proprietary FISH (fluorescent in situ hybridization) based HPV associated cancer test and the granted patent is part of a sequence of patents received for FHACT that provide protections for CGI’s proprietary capabilities...

Rubicon Genomics Inc. has emerged as a world leader with respect to preparation and selling of kits and reagents that speed up genomic analysis, including DNA sequencing, with applications for gene-based research, drug development and diagnostics after going through a tough time in the recent past.

As part of the agreement, Ranbaxy along with its partners Cipher Pharm and Galephar Pharma, has entered into a non-exclusive license agreement with Actavis under the Dublin-headquartered company may start selling its generic version of Absorica in the US on 27 December 2020 (nine months before the expiration of the patents in September 2021) or...

In a relief for US drug major Merck Sharp and Dohme (MSD), Delhi High Court restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American company.

Apple Inc could be facing up to $862 million in damages after a U.S. jury on Tuesday found the iPhone maker used technology owned by the University of Wisconsin-Madison’s licensing arm without permission in chips found in many of its most popular devices.

The United States Patent and Trademark Office (USPTO) published a short Federal Register notice titled Change in Practice Regarding Correction of Foreign Priority Claims.

The Open Invention Network – led by IBM, Google and 5 others – seeks a patent “no-fly zone” for open-source software. The consortium, known as the Open Invention Network, is dedicated to protecting a mode of collaborative invention. Specifically, it tries to safeguard the Linux open-source software ecosystem—software that’s written collaboratively and distributed for free—from...

A $600 million patent licensing dispute over the use of Botox to treat migraine headaches has been resolved in Allergan PLC’s favor with a U.S. judge scolding Miotox LLC for making “tedious and convoluted” arguments to prove its case.

An Asian-American rock band called The Slants asked a federal appeals court last week to trademark its name even though the government says it disparages Asians.

Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced that the Company has filed a patent for systems and methods for predicting treatment outcomes from chemotherapy.